{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:46:37Z","timestamp":1793411197306,"version":"4.5.0"},"reference-count":213,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903829"],"award-info":[{"award-number":["81903829"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint project of Luzhou Municipal People\u2019s Government and Southwest Medical University, China","award":["2018LZXNYD-ZK42"],"award-info":[{"award-number":["2018LZXNYD-ZK42"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12035-022-02944-x","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T12:06:57Z","timestamp":1657714017000},"page":"5935-5954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The Key Role of Magnetic Resonance Imaging in the Detection of Neurodegenerative Diseases-Associated Biomarkers: A Review"],"prefix":"10.1007","volume":"59","author":[{"given":"Ke-Ru","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Guo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Peng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-Lin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Qiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8873-9138","authenticated-orcid":false,"given":"Lu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"issue":"16","key":"2944_CR1","doi-asserted-by":"publisher","first-page":"8978","DOI":"10.3390\/ijms22168978","volume":"22","author":"JL Zugaza","year":"2021","unstructured":"Zugaza JL (2021) Cell signaling in neurodegeneration. Int J Mol Sci 22(16):8978","journal-title":"Int J Mol Sci"},{"key":"2944_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mcna.2019.11.001","volume":"104","author":"A Capizzi","year":"2020","unstructured":"Capizzi A, Woo J, Verduzco-Gutierrez M (2020) Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management. Med Clin North Am 104:213\u2013238","journal-title":"Med Clin North Am"},{"key":"2944_CR3","doi-asserted-by":"publisher","first-page":"107695","DOI":"10.1016\/j.pharmthera.2020.107695","volume":"216","author":"T Tao","year":"2020","unstructured":"Tao T, Liu M, Chen M, Luo Y, Wang C, Xu T, Jiang Y, Guo Y, et al (2020) Natural medicine in neuroprotection for ischemic stroke: challenges and prospective. Pharmacol Ther 216:107695","journal-title":"Pharmacol Ther"},{"key":"2944_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","volume":"16","author":"Group GBDNDC","year":"2017","unstructured":"Group GBDNDC (2017) Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 16:877\u2013897","journal-title":"Lancet Neurol"},{"key":"2944_CR5","doi-asserted-by":"crossref","unstructured":"Erkkinen MG, Kim MO, Geschwind MD (2018) Clinical neurology and epidemiology of the major neurodegenerative diseases.Cold Spring Harb Perspect Biol 10(4):a033118","DOI":"10.1101\/cshperspect.a033118"},{"key":"2944_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.3457","volume":"20","author":"J Guo","year":"2014","unstructured":"Guo J, Lee VJNM (2014) Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 20:130\u2013138","journal-title":"Nat Med"},{"key":"2944_CR7","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3389\/fnins.2019.00728","volume":"13","author":"X Castillo","year":"2019","unstructured":"Castillo X, Castro-Obreg\u00f3n S, Guti\u00e9rrez-Becker B, Guti\u00e9rrez-Ospina G, Karalis N, Khalil A, Lopez-Noguerola J, Rodr\u00edguez L et al (2019) Re-thinking the etiological framework of neurodegeneration. Front Neurosci 13:728","journal-title":"Front Neurosci"},{"key":"2944_CR8","doi-asserted-by":"crossref","unstructured":"Dugger BN, Dickson DW (2017) Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol 9(7):a028035","DOI":"10.1101\/cshperspect.a028035"},{"key":"2944_CR9","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1093\/brain\/awl254","volume":"129","author":"KP Rankin","year":"2006","unstructured":"Rankin KP, Gorno-Tempini ML, Allison SC, Stanley CM, Glenn S, Weiner MW, Miller BL (2006) Structural anatomy of empathy in neurodegenerative disease. Brain 129:2945\u20132956","journal-title":"Brain"},{"key":"2944_CR10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S1474-4422(20)30490-7","volume":"20","author":"LC Jordan","year":"2021","unstructured":"Jordan LC, DeBaun MR, Donahue MJ (2021) Advances in neuroimaging to improve care in sickle cell disease. Lancet Neurol 20:398\u2013408","journal-title":"Lancet Neurol"},{"key":"2944_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nrn3241","volume":"13","author":"G Buzs\u00e1ki","year":"2012","unstructured":"Buzs\u00e1ki G, Anastassiou CA, Koch C (2012) The origin of extracellular fields and currents\u2013EEG, ECoG. LFP and spikes Nat Rev Neurosci 13:407\u2013420","journal-title":"LFP and spikes Nat Rev Neurosci"},{"key":"2944_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:263\u2013269","journal-title":"Alzheimers Dement"},{"key":"2944_CR13","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00415-018-9016-3","volume":"266","author":"A Chandra","year":"2019","unstructured":"Chandra A, Dervenoulas G, Politis M (2019) Alzheimer\u2019s Disease Neuroimaging I: Magnetic resonance imaging in Alzheimer\u2019s disease and mild cognitive impairment. J Neurol 266:1293\u20131302","journal-title":"J Neurol"},{"key":"2944_CR14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson O (2021) Biomarkers for neurodegenerative diseases. Nat Med 27:954\u2013963","journal-title":"Nat Med"},{"key":"2944_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.tips.2015.03.002","volume":"36","author":"K Blennow","year":"2015","unstructured":"Blennow K, Mattsson N, Scholl M, Hansson O, Zetterberg H (2015) Amyloid biomarkers in Alzheimer\u2019s disease. Trends Pharmacol Sci 36:297\u2013309","journal-title":"Trends Pharmacol Sci"},{"key":"2944_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/jnnp-2017-315813","volume":"89","author":"S Koga","year":"2018","unstructured":"Koga S, Dickson DW (2018) Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy. J Neurol Neurosurg Psychiatry 89:175\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2944_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2217\/bmm-2016-0370","volume":"11","author":"K Gwinn","year":"2017","unstructured":"Gwinn K, David KK, Swanson-Fischer C, Albin R, Hillaire-Clarke CS, Sieber BA, Lungu C, Bowman FD et al (2017) Parkinson\u2019s disease biomarkers: perspective from the NINDS Parkinson\u2019s Disease Biomarkers Program. Biomark Med 11:451\u2013473","journal-title":"Biomark Med"},{"key":"2944_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jalz.2016.09.009","volume":"13","author":"SK Herukka","year":"2017","unstructured":"Herukka SK, Simonsen AH, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB et al (2017) Recommendations for cerebrospinal fluid Alzheimer\u2019s disease biomarkers in the diagnostic evaluation of mild cognitive impairment. Alzheimers Dement 13:285\u2013295","journal-title":"Alzheimers Dement"},{"key":"2944_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","volume":"9","author":"PS Aisen","year":"2017","unstructured":"Aisen PS, Cummings J, Jack CR Jr, Morris JC, Sperling R, Frolich L, Jones RW, Dowsett SA et al (2017) On the path to 2025: understanding the Alzheimer\u2019s disease continuum. Alzheimers Res Ther 9:60","journal-title":"Alzheimers Res Ther"},{"key":"2944_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev.pharmtox.41.1.347","volume":"41","author":"LJ Lesko","year":"2001","unstructured":"Lesko LJ, Atkinson AJ Jr (2001) Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol 41:347\u2013366","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2944_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM (2016) Alzheimer\u2019s disease. Lancet 388:505\u2013517","journal-title":"Lancet"},{"issue":"7","key":"2944_CR22","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/alz.12283","volume":"17","author":"J Simren","year":"2021","unstructured":"Simren J, Leuzy A, Karikari TK, Hye A, Benedet AL, Lantero-Rodriguez J, Mattsson-Carlgren N, Scholl M et al (2021) The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer\u2019s disease. Alzheimers Dement 17(7):1145\u20131156","journal-title":"Alzheimers Dement"},{"key":"2944_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/alzrt269","volume":"6","author":"JL Cummings","year":"2014","unstructured":"Cummings JL, Morstorf T, Zhong K (2014) Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther 6:37","journal-title":"Alzheimers Res Ther"},{"key":"2944_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3233\/JAD-171166","volume":"64","author":"T Schirinzi","year":"2018","unstructured":"Schirinzi T, Di Lorenzo F, Sancesario GM, Di Lazzaro G, Ponzo V, Pisani A, Mercuri NB, Koch G et al (2018) Amyloid-mediated cholinergic dysfunction in motor impairment related to Alzheimer\u2019s disease. J Alzheimers Dis 64:525\u2013532","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"2944_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/jpm10030061","volume":"10","author":"C Villa","year":"2020","unstructured":"Villa C, Lavitrano M, Salvatore E, Combi R (2020) Molecular and imaging biomarkers in Alzheimer\u2019s disease: a focus on recent insights. J Pers Med 10(3):61","journal-title":"J Pers Med"},{"key":"2944_CR26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jalz.2018.08.012","volume":"15","author":"K Nho","year":"2019","unstructured":"Nho K, Kueider-Paisley A, MahmoudianDehkordi S, Arnold M, Risacher SL, Louie G, Blach C, Baillie R et al (2019) Altered bile acid profile in mild cognitive impairment and Alzheimer\u2019s disease: relationship to neuroimaging and CSF biomarkers. Alzheimers Dement 15:232\u2013244","journal-title":"Alzheimers Dement"},{"key":"2944_CR27","doi-asserted-by":"publisher","first-page":"e3104","DOI":"10.1212\/WNL.0000000000010747","volume":"95","author":"J Luo","year":"2020","unstructured":"Luo J, Agboola F, Grant E, Masters CL, Albert MS, Johnson SC, McDade EM, Voglein J et al (2020) Sequence of Alzheimer disease biomarker changes in cognitively normal adults: a cross-sectional study. Neurology 95:e3104\u2013e3116","journal-title":"Neurology"},{"key":"2944_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13195-020-00655-w","volume":"12","author":"F Mouton-Liger","year":"2020","unstructured":"Mouton-Liger F, Dumurgier J, Cognat E, Hourregue C, Zetterberg H, Vanderstichele H, Vanmechelen E, Bouaziz-Amar E et al (2020) CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer\u2019s disease. Alzheimers Res Ther 12:88","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"2944_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/jpm10030085","volume":"10","author":"K Zou","year":"2020","unstructured":"Zou K, Abdullah M, Michikawa M (2020) Current biomarkers for Alzheimer\u2019s disease: from CSF to blood. J Pers Med 10(3):85","journal-title":"J Pers Med"},{"key":"2944_CR30","doi-asserted-by":"crossref","unstructured":"Mil\u00e0-Alom\u00e0 M, Brinkmalm A, Ashton NJ, Kvartsberg H, Shekari M, Operto G, Salvad\u00f3 G, Falcon C et al (2021) CSF Synaptic biomarkers in the preclinical stage of Alzheimer disease and their association with MRI and PET: a cross-sectional study. Neurology 97(21):e2065\u2013e2078","DOI":"10.1212\/WNL.0000000000012853"},{"key":"2944_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40708-015-0028-9","volume":"3","author":"Q Zhao","year":"2016","unstructured":"Zhao Q, Chen X, Zhou Y (2016) Quantitative multimodal multiparametric imaging in Alzheimer\u2019s disease. Brain Inform 3:29\u201337","journal-title":"Brain Inform"},{"key":"2944_CR32","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.nicl.2019.101771","volume":"22","author":"J Ottoy","year":"2019","unstructured":"Ottoy J, Niemantsverdriet E, Verhaeghe J, De Roeck E, Struyfs H, Somers C, Wyffels L, Ceyssens S et al (2019) Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and (18)F-FDG-PET imaging. Neuroimage Clin 22:101771","journal-title":"Neuroimage Clin"},{"key":"2944_CR33","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3233\/JAD-180409","volume":"66","author":"S Abu-Rumeileh","year":"2018","unstructured":"Abu-Rumeileh S, Mometto N, Bartoletti-Stella A, Polischi B, Oppi F, Poda R, Stanzani-Maserati M, Cortelli P, Liguori R, Capellari S, Parchi P (2018) Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: a single-center study. J Alzheimers Dis 66:551\u2013563","journal-title":"J Alzheimers Dis"},{"key":"2944_CR34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3233\/JAD-191330","volume":"74","author":"M Okafor","year":"2020","unstructured":"Okafor M, Nye JA, Shokouhi M, Shaw LM, Goldstein F, Hajjar I (2020) 18F-flortaucipir PET associations with cerebrospinal fluid, cognition, and neuroimaging in mild cognitive impairment due to Alzheimer\u2019s disease. J Alzheimers Dis 74:589\u2013601","journal-title":"J Alzheimers Dis"},{"key":"2944_CR35","doi-asserted-by":"publisher","first-page":"101941","DOI":"10.1016\/j.nicl.2019.101941","volume":"24","author":"H Jang","year":"2019","unstructured":"Jang H, Park J, Woo S, Kim S, Kim HJ, Na DL, Lockhart SN, Kim Y et al (2019) Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers. Neuroimage Clin 24:101941","journal-title":"Neuroimage Clin"},{"key":"2944_CR36","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10534-012-9545-7","volume":"25","author":"CD SanMart\u00edn","year":"2012","unstructured":"SanMart\u00edn CD, Paula-Lima AC, Hidalgo C, N\u00fa\u00f1ez MT (2012) Sub-lethal levels of amyloid \u03b2-peptide oligomers decrease non-transferrin-bound iron uptake and do not potentiate iron toxicity in primary hippocampal neurons. Biometals 25:805\u2013813","journal-title":"Biometals"},{"key":"2944_CR37","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.chembiol.2017.07.014","volume":"24","author":"ND Telling","year":"2017","unstructured":"Telling ND, Everett J, Collingwood JF, Dobson J, van der Laan G, Gallagher JJ, Wang J, Hitchcock AP (2017) Iron biochemistry is correlated with amyloid plaque morphology in an established mouse model of Alzheimer\u2019s disease. Cell Chem Biol 24:1205-1215.e1203","journal-title":"Cell Chem Biol"},{"key":"2944_CR38","doi-asserted-by":"publisher","first-page":"e81093","DOI":"10.1371\/journal.pone.0081093","volume":"8","author":"J Acosta-Cabronero","year":"2013","unstructured":"Acosta-Cabronero J, Williams GB, Cardenas-Blanco A, Arnold RJ, Lupson V, Nestor PJ (2013) In vivo quantitative susceptibility mapping (QSM) in Alzheimer\u2019s disease. PLoS ONE 8:e81093","journal-title":"PLoS ONE"},{"key":"2944_CR39","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1021\/acschemneuro.8b00194","volume":"9","author":"L Du","year":"2018","unstructured":"Du L, Zhao Z, Cui A, Zhu Y, Zhang L, Liu J, Shi S, Fu C et al (2018) Increased iron deposition on brain quantitative susceptibility mapping correlates with decreased cognitive function in Alzheimer\u2019s disease. ACS Chem Neurosci 9:1849\u20131857","journal-title":"ACS Chem Neurosci"},{"key":"2944_CR40","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3233\/JAD-200843","volume":"78","author":"D Li","year":"2020","unstructured":"Li D, Liu Y, Zeng X, Xiong Z, Yao Y, Liang D, Qu H, Xiang H et al (2020) Quantitative study of the changes in cerebral blood flow and iron deposition during progression of Alzheimer\u2019s disease. J Alzheimers Dis 78:439\u2013452","journal-title":"J Alzheimers Dis"},{"key":"2944_CR41","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1148\/radiol.2532082324","volume":"253","author":"WZ Zhu","year":"2009","unstructured":"Zhu WZ, Zhong WD, Wang W, Zhan CJ, Wang CY, Qi JP, Wang JZ, Lei T (2009) Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology 253:497\u2013504","journal-title":"Radiology"},{"key":"2944_CR42","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34:939\u2013944","journal-title":"Neurology"},{"key":"2944_CR43","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1148\/radiol.2020192541","volume":"296","author":"A Damulina","year":"2020","unstructured":"Damulina A, Pirpamer L, Soellradl M, Sackl M, Tinauer C, Hofer E, Enzinger C, Gesierich B et al (2020) Cross-sectional and longitudinal assessment of brain iron level in Alzheimer disease using 3-T MRI. Radiology 296:619\u2013626","journal-title":"Radiology"},{"key":"2944_CR44","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1021\/acs.accounts.9b00248","volume":"52","author":"Y Liu","year":"2019","unstructured":"Liu Y, Nguyen M, Robert A, Meunier B (2019) Metal ions in Alzheimer\u2019s disease: a key role or not? Acc Chem Res 52:2026\u20132035","journal-title":"Acc Chem Res"},{"key":"2944_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13195-018-0434-3","volume":"10","author":"G Benson","year":"2018","unstructured":"Benson G, Hildebrandt A, Lange C, Schwarz C, Kobe T, Sommer W, Floel A, Wirth M (2018) Functional connectivity in cognitive control networks mitigates the impact of white matter lesions in the elderly. Alzheimers Res Ther 10:109","journal-title":"Alzheimers Res Ther"},{"key":"2944_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13195-020-00759-3","volume":"13","author":"M Gaubert","year":"2021","unstructured":"Gaubert M, Lange C, Garnier-Crussard A, Kobe T, Bougacha S, Gonneaud J, de Flores R, Tomadesso C et al (2021) Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer\u2019s disease. Alzheimers Res Ther 13:29","journal-title":"Alzheimers Res Ther"},{"key":"2944_CR47","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/ana.25905","volume":"88","author":"PJ Lao","year":"2020","unstructured":"Lao PJ, Gutierrez J, Keator D, Rizvi B, Banerjee A, Igwe KC, Laing KK, Sathishkumar M et al (2020) Alzheimer-related cerebrovascular disease in Down syndrome. Ann Neurol 88:1165\u20131177","journal-title":"Ann Neurol"},{"key":"2944_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neurobiolaging.2020.03.008","volume":"91","author":"P Walsh","year":"2020","unstructured":"Walsh P, Sudre CH, Fiford CM, Ryan NS, Lashley T, Frost C, Barnes J (2020) CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer\u2019s disease. Neurobiol Aging 91:5\u201314","journal-title":"Neurobiol Aging"},{"key":"2944_CR49","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1176\/appi.neuropsych.17120366","volume":"31","author":"S Ranjbar","year":"2019","unstructured":"Ranjbar S, Velgos SN, Dueck AC, Geda YE, Mitchell JR (2019) Brain MR radiomics to differentiate cognitive disorders. J Neuropsychiatry Clin Neurosci 31:210\u2013219","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2944_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1179\/174313211X12966635733358","volume":"14","author":"LR Freeman","year":"2011","unstructured":"Freeman LR, Haley-Zitlin V, Stevens C, Granholm AC (2011) Diet-induced effects on neuronal and glial elements in the middle-aged rat hippocampus. Nutr Neurosci 14:32\u201344","journal-title":"Nutr Neurosci"},{"key":"2944_CR51","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13024-020-00378-4","volume":"15","author":"HR Bulgart","year":"2020","unstructured":"Bulgart HR, Neczypor EW, Wold LE, Mackos AR (2020) Microbial involvement in Alzheimer disease development and progression. Mol Neurodegener 15:42","journal-title":"Mol Neurodegener"},{"key":"2944_CR52","doi-asserted-by":"publisher","first-page":"e2577","DOI":"10.1212\/WNL.0000000000010728","volume":"95","author":"YY Lim","year":"2020","unstructured":"Lim YY, Baker JE, Bruns L Jr, Mills A, Fowler C, Fripp J, Rainey-Smith SR, Ames D et al (2020) Association of deficits in short-term learning and A\u03b2 and hippocampal volume in cognitively normal adults. Neurology 95:e2577\u2013e2585","journal-title":"Neurology"},{"key":"2944_CR53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/WAD.0000000000000225","volume":"32","author":"D Andriuta","year":"2018","unstructured":"Andriuta D, Moullart V, Schraen S, Devendeville A, Meyer ME, Godefroy O (2018) Inferior parietal cortex hypoperfusion is the most specific imaging marker for AD patients with positive CSF biomarker assays in a memory clinic in France. Alzheimer Dis Assoc Disord 32:89\u201393","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2944_CR54","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jalz.2016.12.009","volume":"13","author":"AC Burggren","year":"2017","unstructured":"Burggren AC, Mahmood Z, Harrison TM, Siddarth P, Miller KJ, Small GW, Merrill DA, Bookheimer SY (2017) Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE \u03b54 variant. Alzheimers Dement 13:739\u2013748","journal-title":"Alzheimers Dement"},{"key":"2944_CR55","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/hbm.23091","volume":"37","author":"L S\u00f8rensen","year":"2016","unstructured":"S\u00f8rensen L, Igel C, Liv Hansen N, Osler M, Lauritzen M, Rostrup E, Nielsen M (2016) Early detection of Alzheimer\u2019s disease using MRI hippocampal texture. Hum Brain Mapp 37:1148\u20131161","journal-title":"Hum Brain Mapp"},{"key":"2944_CR56","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.nicl.2016.11.025","volume":"13","author":"L S\u00f8rensen","year":"2017","unstructured":"S\u00f8rensen L, Igel C, Pai A, Balas I, Anker C, Lillholm M, Nielsen M (2017) Differential diagnosis of mild cognitive impairment and Alzheimer\u2019s disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry. Neuroimage Clin 13:470\u2013482","journal-title":"Neuroimage Clin"},{"key":"2944_CR57","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fnbeh.2013.00194","volume":"7","author":"N Urbanowitsch","year":"2013","unstructured":"Urbanowitsch N, Gorenc L, Herold CJ, Schroder J (2013) Autobiographical memory: a clinical perspective. Front Behav Neurosci 7:194","journal-title":"Front Behav Neurosci"},{"key":"2944_CR58","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2174\/156720512800492558","volume":"9","author":"PA Thomann","year":"2012","unstructured":"Thomann PA, Seidl U, Brinkmann J, Hirjak D, Traeger T, Wolf RC, Essig M, Schroder J (2012) Hippocampal morphology and autobiographic memory in mild cognitive impairment and Alzheimer\u2019s disease. Curr Alzheimer Res 9:507\u2013515","journal-title":"Curr Alzheimer Res"},{"key":"2944_CR59","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/hipo.22726","volume":"27","author":"D Hirjak","year":"2017","unstructured":"Hirjak D, Wolf RC, Remmele B, Seidl U, Thomann AK, Kubera KM, Schroder J, Maier-Hein KH et al (2017) Hippocampal formation alterations differently contribute to autobiographic memory deficits in mild cognitive impairment and Alzheimer\u2019s disease. Hippocampus 27:702\u2013715","journal-title":"Hippocampus"},{"key":"2944_CR60","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3233\/JAD-160014","volume":"54","author":"EC Gertje","year":"2016","unstructured":"Gertje EC, Pluta J, Das S, Mancuso L, Kliot D, Yushkevich P, Wolk D (2016) Clinical Application of automatic segmentation of medial temporal lobe subregions in prodromal and dementia-level Alzheimer\u2019s disease. J Alzheimers Dis 54:1027\u20131037","journal-title":"J Alzheimers Dis"},{"key":"2944_CR61","doi-asserted-by":"publisher","first-page":"10912","DOI":"10.1038\/s41598-020-67873-y","volume":"10","author":"GW Kim","year":"2020","unstructured":"Kim GW, Kim BC, Park KS, Jeong GW (2020) A pilot study of brain morphometry following donepezil treatment in mild cognitive impairment: volume changes of cortical\/subcortical regions and hippocampal subfields. Sci Rep 10:10912","journal-title":"Sci Rep"},{"key":"2944_CR62","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s13311-021-01026-5","volume":"18","author":"RF Buckley","year":"2021","unstructured":"Buckley RF (2021) Recent advances in imaging of preclinical, sporadic, and autosomal dominant Alzheimer\u2019s disease. Neurotherapeutics 18:709\u2013727","journal-title":"Neurotherapeutics"},{"key":"2944_CR63","doi-asserted-by":"crossref","unstructured":"Caunca MR, Del Brutto V, Gardener H, Shah N, Dequatre-Ponchelle N, Cheung YK, Elkind MS, Brown TR et al (2016) Cerebral microbleeds, vascular risk factors, and magnetic resonance imaging markers: the Northern Manhattan study. J Am Heart Assoc 5(9):e003477","DOI":"10.1161\/JAHA.116.003477"},{"key":"2944_CR64","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1161\/STROKEAHA.111.620179","volume":"42","author":"BR Choi","year":"2011","unstructured":"Choi BR, Lee SR, Han JS, Woo SK, Kim KM, Choi DH, Kwon KJ, Han SH et al (2011) Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model. Stroke 42:2595\u20132604","journal-title":"Stroke"},{"key":"2944_CR65","doi-asserted-by":"publisher","first-page":"e2845","DOI":"10.1212\/WNL.0000000000011029","volume":"95","author":"FN Saridin","year":"2020","unstructured":"Saridin FN, Hilal S, Villaraza SG, Reilhac A, Gyanwali B, Tanaka T, Stephenson MC, Ng SL et al (2020) Brain amyloid \u03b2, cerebral small vessel disease, and cognition: a memory clinic study. Neurology 95:e2845\u2013e2853","journal-title":"Neurology"},{"key":"2944_CR66","first-page":"637","volume":"20","author":"F Fazekas","year":"1999","unstructured":"Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, Hartung HP (1999) Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 20:637\u2013642","journal-title":"AJNR Am J Neuroradiol"},{"key":"2944_CR67","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/bpa.12181","volume":"24","author":"S Tikka","year":"2014","unstructured":"Tikka S, Baumann M, Siitonen M, Pasanen P, P\u00f6yh\u00f6nen M, Myllykangas L, Viitanen M, Fukutake T et al (2014) CADASIL and CARASIL. Brain Pathol 24:525\u2013544","journal-title":"Brain Pathol"},{"key":"2944_CR68","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1161\/STROKEAHA.119.026235","volume":"51","author":"HH Tsai","year":"2020","unstructured":"Tsai HH, Pasi M, Tsai LK, Chen YF, Chen YW, Tang SC, Gurol ME, Yen RF et al (2020) Superficial cerebellar microbleeds and cerebral amyloid angiopathy: a magnetic resonance imaging\/positron emission tomography study. Stroke 51:202\u2013208","journal-title":"Stroke"},{"key":"2944_CR69","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00401-005-1074-9","volume":"110","author":"J Attems","year":"2005","unstructured":"Attems J (2005) Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol 110:345\u2013359","journal-title":"Acta Neuropathol"},{"key":"2944_CR70","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nrneurol.2015.194","volume":"11","author":"C Enzinger","year":"2015","unstructured":"Enzinger C, Barkhof F, Ciccarelli O, Filippi M, Kappos L, Rocca MA, Ropele S, Rovira \u00c0 et al (2015) Nonconventional MRI and microstructural cerebral changes in multiple sclerosis. Nat Rev Neurol 11:676\u2013686","journal-title":"Nat Rev Neurol"},{"key":"2944_CR71","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3174\/ajnr.A1355","volume":"30","author":"RN Nandigam","year":"2009","unstructured":"Nandigam RN, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J, Greenberg SM, Dickerson BC (2009) MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol 30:338\u2013343","journal-title":"AJNR Am J Neuroradiol"},{"key":"2944_CR72","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1161\/STROKEAHA.110.599837","volume":"42","author":"JD Goos","year":"2011","unstructured":"Goos JD, van der Flier WM, Knol DL, Pouwels PJ, Scheltens P, Barkhof F, Wattjes MP (2011) Clinical relevance of improved microbleed detection by susceptibility-weighted magnetic resonance imaging. Stroke 42:1894\u20131900","journal-title":"Stroke"},{"key":"2944_CR73","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/JAD-170470","volume":"60","author":"H Basselerie","year":"2017","unstructured":"Basselerie H, Bracoud L, Zeestraten E, Bouguen E, Kiyasova V, Pueyo M, Cognard C, Dumas H et al (2017) Incident cerebral microbleeds detected by susceptibility weight-imaging help to identify patients with mild cognitive impairment progressing to Alzheimer\u2019s disease. J Alzheimers Dis 60:253\u2013262","journal-title":"J Alzheimers Dis"},{"key":"2944_CR74","first-page":"1717","volume":"29","author":"C Masson","year":"2000","unstructured":"Masson C, Leys D, Bu\u00e9e L (2000) Cerebral amyloid angiopathies. Presse Med 29:1717\u20131722","journal-title":"Presse Med"},{"key":"2944_CR75","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1177\/1971400916689483","volume":"30","author":"G Sparacia","year":"2017","unstructured":"Sparacia G, Agnello F, La Tona G, Iaia A, Midiri F, Sparacia B (2017) Assessment of cerebral microbleeds by susceptibility-weighted imaging in Alzheimer\u2019s disease patients: a neuroimaging biomarker of the disease. Neuroradiol J 30:330\u2013335","journal-title":"Neuroradiol J"},{"key":"2944_CR76","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci 12:723\u2013738","journal-title":"Nat Rev Neurosci"},{"key":"2944_CR77","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11357-017-9991-9","volume":"39","author":"A Csiszar","year":"2017","unstructured":"Csiszar A, Tarantini S, F\u00fcl\u00f6p GA, Kiss T, Valcarcel-Ares MN, Galvan V, Ungvari Z, Yabluchanskiy A (2017) Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer\u2019s disease. Geroscience 39:359\u2013372","journal-title":"Geroscience"},{"key":"2944_CR78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neurobiolaging.2019.12.003","volume":"88","author":"C Pettigrew","year":"2020","unstructured":"Pettigrew C, Soldan A, Zhu Y, Cai Q, Wang MC, Moghekar A, Miller MI, Singh B et al (2020) Cognitive reserve and rate of change in Alzheimer\u2019s and cerebrovascular disease biomarkers among cognitively normal individuals. Neurobiol Aging 88:33\u201341","journal-title":"Neurobiol Aging"},{"issue":"Pt 1","key":"2944_CR79","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.neuroimage.2013.04.113","volume":"85","author":"M Fabiani","year":"2014","unstructured":"Fabiani M, Gordon BA, Maclin EL, Pearson MA, Brumback-Peltz CR, Low KA, McAuley E, Sutton BP et al (2014) Neurovascular coupling in normal aging: a combined optical. ERP and fMRI study Neuroimage 85(Pt 1):592\u2013607","journal-title":"ERP and fMRI study Neuroimage"},{"key":"2944_CR80","doi-asserted-by":"crossref","first-page":"e13057","DOI":"10.1111\/acel.13057","volume":"19","author":"CE Van Skike","year":"2020","unstructured":"Van Skike CE, Lin AL, Roberts Burbank R, Halloran JJ, Hernandez SF, Cuvillier J, Soto VY, Hussong SA et al (2020) mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging. Aging Cell 19:e13057","journal-title":"Aging Cell"},{"key":"2944_CR81","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/ana.22015","volume":"68","author":"R Hamilton","year":"2010","unstructured":"Hamilton R, Patel S, Lee EB, Jackson EM, Lopinto J, Arnold SE, Clark CM, Basil A et al (2010) Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann Neurol 68:535\u2013540","journal-title":"Ann Neurol"},{"key":"2944_CR82","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.molmed.2019.11.008","volume":"26","author":"BC Reeves","year":"2020","unstructured":"Reeves BC, Karimy JK, Kundishora AJ, Mestre H, Cerci HM, Matouk C, Alper SL, Lundgaard I et al (2020) Glymphatic system impairment in Alzheimer\u2019s disease and idiopathic normal pressure hydrocephalus. Trends Mol Med 26:285\u2013295","journal-title":"Trends Mol Med"},{"key":"2944_CR83","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/WAD.0b013e3181b4f736","volume":"24","author":"LL Chao","year":"2010","unstructured":"Chao LL, Buckley ST, Kornak J, Schuff N, Madison C, Yaffe K, Miller BL, Kramer JH et al (2010) ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord 24:19\u201327","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2944_CR84","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/psyg.12435","volume":"19","author":"S Azuma","year":"2019","unstructured":"Azuma S, Kazui H, Kanemoto H, Suzuki Y, Sato S, Suehiro T, Matsumoto T, Yoshiyama K et al (2019) Cerebral blood flow and Alzheimer\u2019s disease-related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus. Psychogeriatrics 19:527\u2013538","journal-title":"Psychogeriatrics"},{"key":"2944_CR85","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.jalz.2018.07.219","volume":"16","author":"Y Stern","year":"2020","unstructured":"Stern Y, Arenaza-Urquijo EM, Bartr\u00e9s-Faz D, Belleville S, Cantilon M, Chetelat G, Ewers M, Franzmeier N et al (2020) Whitepaper: defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimers Dement 16:1305\u20131311","journal-title":"Alzheimers Dement"},{"key":"2944_CR86","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1212\/WNL.0b013e318227b227","volume":"77","author":"S Debette","year":"2011","unstructured":"Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, Wolf PA, DeCarli C (2011) Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 77:461\u2013468","journal-title":"Neurology"},{"key":"2944_CR87","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.trci.2015.06.004","volume":"1","author":"K Ritchie","year":"2015","unstructured":"Ritchie K, Ritchie CW, Yaffe K, Skoog I, Scarmeas N (2015) Is late-onset Alzheimer\u2019s disease really a disease of midlife? Alzheimers Dement (N Y) 1:122\u2013130","journal-title":"Alzheimers Dement (N Y)"},{"key":"2944_CR88","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fnagi.2019.00355","volume":"11","author":"BJ Neth","year":"2019","unstructured":"Neth BJ, Graff-Radford J, Mielke MM, Przybelski SA, Lesnick TG, Schwarz CG, Reid RI, Senjem ML et al (2019) Relationship Between risk factors and brain reserve in late middle age: implications for cognitive aging. Front Aging Neurosci 11:355","journal-title":"Front Aging Neurosci"},{"key":"2944_CR89","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/B978-0-12-804766-8.00011-X","volume":"167","author":"Y Stern","year":"2019","unstructured":"Stern Y, Barulli D (2019) Cognitive reserve. Handb Clin Neurol 167:181\u2013190","journal-title":"Handb Clin Neurol"},{"key":"2944_CR90","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neubiorev.2018.03.003","volume":"88","author":"MV Soloveva","year":"2018","unstructured":"Soloveva MV, Jamadar SD, Poudel G, Georgiou-Karistianis N (2018) A critical review of brain and cognitive reserve in Huntington\u2019s disease. Neurosci Biobehav Rev 88:155\u2013169","journal-title":"Neurosci Biobehav Rev"},{"key":"2944_CR91","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neurobiolaging.2019.12.022","volume":"88","author":"C McKenzie","year":"2020","unstructured":"McKenzie C, Bucks RS, Weinborn M, Bourgeat P, Salvado O, Gavett BE (2020) Cognitive reserve predicts future executive function decline in older adults with Alzheimer\u2019s disease pathology but not age-associated pathology. Neurobiol Aging 88:119\u2013127","journal-title":"Neurobiol Aging"},{"key":"2944_CR92","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3389\/fpsyt.2019.00953","volume":"10","author":"S Frenzel","year":"2019","unstructured":"Frenzel S, Wittfeld K, Habes M, Klinger-Konig J, Bulow R, Volzke H, Grabe HJ (2019) A biomarker for Alzheimer\u2019s disease based on patterns of regional brain atrophy. Front Psychiatry 10:953","journal-title":"Front Psychiatry"},{"key":"2944_CR93","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20:385\u2013397","journal-title":"Lancet Neurol"},{"key":"2944_CR94","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1039\/D0CS00115E","volume":"50","author":"L Gao","year":"2021","unstructured":"Gao L, Wang W, Wang X, Yang F, Xie L, Shen J, Brimble MA, Xiao Q et al (2021) Fluorescent probes for bioimaging of potential biomarkers in Parkinson\u2019s disease. Chem Soc Rev 50:1219\u20131250","journal-title":"Chem Soc Rev"},{"key":"2944_CR95","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X, Hu B, Schmeichel A et al (2020) Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578:273\u2013277","journal-title":"Nature"},{"key":"2944_CR96","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2217\/bmm.15.107","volume":"10","author":"L Parnetti","year":"2016","unstructured":"Parnetti L, Cicognola C, Eusebi P, Chiasserini D (2016) Value of cerebrospinal fluid \u03b1-synuclein species as biomarker in Parkinson\u2019s diagnosis and prognosis. Biomark Med 10:35\u201349","journal-title":"Biomark Med"},{"key":"2944_CR97","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.actbio.2021.03.071","volume":"132","author":"AJ Bindas","year":"2021","unstructured":"Bindas AJ, Kulkarni S, Koppes RA, Koppes AN (2021) Parkinson\u2019s disease and the gut: models of an emerging relationship. Acta Biomater 132:325\u2013344","journal-title":"Acta Biomater"},{"key":"2944_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27:27\u201342","journal-title":"Eur J Neurol"},{"key":"2944_CR99","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435\u2013450","journal-title":"Nat Rev Neurosci"},{"key":"2944_CR100","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000354670","volume":"13","author":"Y Compta","year":"2014","unstructured":"Compta Y, Parkkinen L, Kempster P, Selikhova M, Lashley T, Holton JL, Lees AJ, Revesz T (2014) The significance of \u03b1-synuclein, amyloid-\u03b2 and tau pathologies in Parkinson\u2019s disease progression and related dementia. Neurodegener Dis 13:154\u2013156","journal-title":"Neurodegener Dis"},{"key":"2944_CR101","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3233\/JPD-191766","volume":"10","author":"CH Chen","year":"2020","unstructured":"Chen CH, Lee BC, Lin CH (2020) Integrated Plasma and neuroimaging biomarkers associated with motor and cognition severity in Parkinson\u2019s disease. J Parkinsons Dis 10:77\u201388","journal-title":"J Parkinsons Dis"},{"key":"2944_CR102","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/mds.23669","volume":"26","author":"G Halliday","year":"2011","unstructured":"Halliday G, Lees A, Stern M (2011) Milestones in Parkinson\u2019s disease\u2013clinical and pathologic features. Mov Disord 26:1015\u20131021","journal-title":"Mov Disord"},{"key":"2944_CR103","doi-asserted-by":"publisher","first-page":"e718","DOI":"10.1212\/WNL.0000000000008677","volume":"94","author":"MC Campbell","year":"2020","unstructured":"Campbell MC, Jackson JJ, Koller JM, Snyder AZ, Kotzbauer PT, Perlmutter JS (2020) Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson disease. Neurology 94:e718\u2013e728","journal-title":"Neurology"},{"issue":"9","key":"2944_CR104","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/ph14090847","volume":"14","author":"\u0160 Korat","year":"2021","unstructured":"Korat \u0160, Bidesi NSR, Bonanno F, Di Nanni A, Ho\u00e0ng ANN, Herfert K, Maurer A, Battisti UM et al (2021) Alpha-synuclein PET tracer development-an overview about current efforts. Pharmaceuticals (Basel) 14(9):847","journal-title":"Pharmaceuticals (Basel)"},{"key":"2944_CR105","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"HC Cheng","year":"2010","unstructured":"Cheng HC, Ulane CM, Burke RE (2010) Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 67:715\u2013725","journal-title":"Ann Neurol"},{"key":"2944_CR106","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3389\/fneur.2019.01329","volume":"10","author":"JC Blair","year":"2019","unstructured":"Blair JC, Barrett MJ, Patrie J, Flanigan JL, Sperling SA, Elias WJ, Druzgal TJ (2019) Brain MRI reveals ascending atrophy in Parkinson\u2019s disease across severity. Front Neurol 10:1329","journal-title":"Front Neurol"},{"key":"2944_CR107","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.3457","volume":"20","author":"JL Guo","year":"2014","unstructured":"Guo JL, Lee VMY (2014) Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 20:130\u2013138","journal-title":"Nat Med"},{"key":"2944_CR108","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jpsychires.2018.04.016","volume":"102","author":"LF Vasconcellos","year":"2018","unstructured":"Vasconcellos LF, Pereira JS, Adachi M, Greca D, Cruz M, Malak AL, Charchat-Fichman H (2018) Volumetric brain analysis as a predictor of a worse cognitive outcome in Parkinson\u2019s disease. J Psychiatr Res 102:254\u2013260","journal-title":"J Psychiatr Res"},{"key":"2944_CR109","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4:19","journal-title":"Transl Neurodegener"},{"key":"2944_CR110","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1523\/JNEUROSCI.2092-19.2019","volume":"40","author":"M Truelove-Hill","year":"2020","unstructured":"Truelove-Hill M, Erus G, Bashyam V, Varol E, Sako C, Gur RC, Gur RE, Koutsouleris N et al (2020) A multidimensional neural maturation index reveals reproducible developmental patterns in children and adolescents. J Neurosci 40:1265\u20131275","journal-title":"J Neurosci"},{"key":"2944_CR111","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.dadm.2018.02.007","volume":"10","author":"AM Racine","year":"2018","unstructured":"Racine AM, Brickhouse M, Wolk DA, Dickerson BC (2018) Alzheimer\u2019s Disease Neuroimaging I: The personalized Alzheimer\u2019s disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment. Alzheimers Dement (Amst) 10:301\u2013310","journal-title":"Alzheimers Dement (Amst)"},{"key":"2944_CR112","doi-asserted-by":"publisher","first-page":"e2015","DOI":"10.1212\/WNL.0000000000007373","volume":"92","author":"SW Kang","year":"2019","unstructured":"Kang SW, Jeon S, Yoo HS, Chung SJ, Lee PH, Sohn YH, Yun M, Evans AC et al (2019) Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction. Neurology 92:e2015\u2013e2026","journal-title":"Neurology"},{"key":"2944_CR113","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/bs.irn.2018.10.005","volume":"144","author":"Z Balazova","year":"2019","unstructured":"Balazova Z, Novakova M, Minsterova A, Rektorova I (2019) Structural and functional magnetic resonance imaging of dementia with lewy bodies. Int Rev Neurobiol 144:95\u2013141","journal-title":"Int Rev Neurobiol"},{"key":"2944_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102196","volume":"26","author":"R Ye","year":"2020","unstructured":"Ye R, Touroutoglou A, Brickhouse M, Katz S, Growdon JH, Johnson KA, Dickerson BC, Gomperts SN (2020) Topography of cortical thinning in the Lewy body diseases. Neuroimage Clin 26:102196","journal-title":"Neuroimage Clin"},{"key":"2944_CR115","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/pmic.201300342","volume":"14","author":"V Licker","year":"2014","unstructured":"Licker V, Turck N, Kovari E, Burkhardt K, Cote M, Surini-Demiri M, Lobrinus JA, Sanchez JC et al (2014) Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson\u2019s disease pathogenesis. Proteomics 14:784\u2013794","journal-title":"Proteomics"},{"key":"2944_CR116","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10072-019-04143-4","volume":"41","author":"S Kumari","year":"2020","unstructured":"Kumari S, Goyal V, Kumaran SS, Dwivedi SN, Srivastava A, Jagannathan NR (2020) Quantitative metabolomics of saliva using proton NMR spectroscopy in patients with Parkinson\u2019s disease and healthy controls. Neurol Sci 41:1201\u20131210","journal-title":"Neurol Sci"},{"key":"2944_CR117","doi-asserted-by":"crossref","unstructured":"(2021) Corrigendum to: Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson\u2019s disease. Brain 144:e24","DOI":"10.1093\/brain\/awaa355"},{"key":"2944_CR118","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1002\/hbm.25406","volume":"42","author":"YH Sung","year":"2021","unstructured":"Sung YH, Noh Y, Kim EY (2021) Early-stage Parkinson\u2019s disease: abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin-sensitive MRI. Hum Brain Mapp 42:2823\u20132832","journal-title":"Hum Brain Mapp"},{"key":"2944_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2018.12.013","volume":"58","author":"N Pavese","year":"2019","unstructured":"Pavese N (2019) Is neuromelanin the imaging biomarker for the early diagnosis of Parkinson\u2019s disease that we were looking for? Parkinsonism Relat Disord 58:1\u20132","journal-title":"Parkinsonism Relat Disord"},{"key":"2944_CR120","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41467-019-08858-y","volume":"10","author":"I Carballo-Carbajal","year":"2019","unstructured":"Carballo-Carbajal I, Laguna A, Romero-Gim\u00e9nez J, Cuadros T, Bov\u00e9 J, Martinez-Vicente M, Parent A, Gonzalez-Sepulveda M et al (2019) Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson\u2019s disease pathogenesis. Nat Commun 10:973","journal-title":"Nat Commun"},{"key":"2944_CR121","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/brain\/awaa461","volume":"144","author":"NP Oxtoby","year":"2021","unstructured":"Oxtoby NP, Leyland LA, Aksman LM, Thomas GEC, Bunting EL, Wijeratne PA, Young AL, Zarkali A et al (2021) Sequence of clinical and neurodegeneration events in Parkinson\u2019s disease progression. Brain 144:975\u2013988","journal-title":"Brain"},{"key":"2944_CR122","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/mdc3.12590","volume":"5","author":"N Pavese","year":"2018","unstructured":"Pavese N, Tai YF (2018) Nigrosome imaging and neuromelanin sensitive MRI in diagnostic evaluation of Parkinsonism. Mov Disord Clin Pract 5:131\u2013140","journal-title":"Mov Disord Clin Pract"},{"key":"2944_CR123","doi-asserted-by":"crossref","unstructured":"Singh S, Nimse SB, Mathew DE, Dhimmar A, Sahastrabudhe H, Gajjar A, Ghadge VA, Kumar P et al (2021) Microbial melanin: recent advances in biosynthesis, extraction, characterization, and applications. Biotechnol Adv 53:107773","DOI":"10.1016\/j.biotechadv.2021.107773"},{"key":"2944_CR124","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3233\/JPD-171263","volume":"8","author":"A Bose","year":"2018","unstructured":"Bose A, Petsko GA, Eliezer D (2018) Parkinson\u2019s disease and melanoma: co-occurrence and mechanisms. J Parkinsons Dis 8:385\u2013398","journal-title":"J Parkinsons Dis"},{"key":"2944_CR125","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1039\/C9AN02213A","volume":"145","author":"H Seo","year":"2020","unstructured":"Seo H, Clark HA (2020) Gadolinium-based MRI contrast agent for the detection of tyrosinase. Analyst 145:1169\u20131173","journal-title":"Analyst"},{"key":"2944_CR126","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12974-018-1179-4","volume":"15","author":"EG Hain","year":"2018","unstructured":"Hain EG, Sparenberg M, Rasi\u0144ska J, Klein C, Aky\u00fcz L, Steiner B (2018) Indomethacin promotes survival of new neurons in the adult murine hippocampus accompanied by anti-inflammatory effects following MPTP-induced dopamine depletion. J Neuroinflammation 15:162","journal-title":"J Neuroinflammation"},{"key":"2944_CR127","doi-asserted-by":"publisher","first-page":"10547","DOI":"10.1038\/s41598-017-10593-7","volume":"7","author":"YS Piao","year":"2017","unstructured":"Piao YS, Lian TH, Hu Y, Zuo LJ, Guo P, Yu SY, Liu L, Jin Z et al (2017) Restless legs syndrome in Parkinson disease: clinical characteristics, abnormal iron metabolism and altered neurotransmitters. Sci Rep 7:10547","journal-title":"Sci Rep"},{"key":"2944_CR128","doi-asserted-by":"publisher","first-page":"10478","DOI":"10.3390\/ijms130810478","volume":"13","author":"H Kumar","year":"2012","unstructured":"Kumar H, Lim HW, More SV, Kim BW, Koppula S, Kim IS, Choi DK (2012) The role of free radicals in the aging brain and Parkinson\u2019s disease: convergence and parallelism. Int J Mol Sci 13:10478\u201310504","journal-title":"Int J Mol Sci"},{"key":"2944_CR129","doi-asserted-by":"publisher","first-page":"946813","DOI":"10.1155\/2012\/946813","volume":"2012","author":"IV Lima","year":"2012","unstructured":"Lima IV, Bastos LF, Limbor\u00e7o-Filho M, Fiebich BL, de Oliveira AC (2012) Role of prostaglandins in neuroinflammatory and neurodegenerative diseases. Mediators Inflamm 2012:946813","journal-title":"Mediators Inflamm"},{"key":"2944_CR130","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/mds.26883","volume":"32","author":"J Langley","year":"2017","unstructured":"Langley J, Huddleston DE, Sedlacik J, Boelmans K, Hu XP (2017) Parkinson\u2019s disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta. Mov Disord 32:441\u2013449","journal-title":"Mov Disord"},{"key":"2944_CR131","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/acn3.50962","volume":"7","author":"TR Barber","year":"2020","unstructured":"Barber TR, Griffanti L, Bradley KM, McGowan DR, Lo C, Mackay CE, Hu MT, Klein JC (2020) Nigrosome 1 imaging in REM sleep behavior disorder and its association with dopaminergic decline. Ann Clin Transl Neurol 7:26\u201335","journal-title":"Ann Clin Transl Neurol"},{"key":"2944_CR132","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3389\/fneur.2019.00747","volume":"10","author":"H Sheng","year":"2019","unstructured":"Sheng H, Zhao B, Ge Y (2019) Blood perfusion and cellular microstructural changes associated with iron deposition in multiple sclerosis lesions. Front Neurol 10:747","journal-title":"Front Neurol"},{"key":"2944_CR133","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/mds.27730","volume":"34","author":"N Bergsland","year":"2019","unstructured":"Bergsland N, Zivadinov R, Schweser F, Hagemeier J, Lichter D, Guttuso T Jr (2019) Ventral posterior substantia nigra iron increases over 3 years in Parkinson\u2019s disease. Mov Disord 34:1006\u20131013","journal-title":"Mov Disord"},{"key":"2944_CR134","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/jmri.22752","volume":"35","author":"AK Lotfipour","year":"2012","unstructured":"Lotfipour AK, Wharton S, Schwarz ST, Gontu V, Sch\u00e4fer A, Peters AM, Bowtell RW, Auer DP et al (2012) High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson\u2019s disease. J Magn Reson Imaging 35:48\u201355","journal-title":"J Magn Reson Imaging"},{"key":"2944_CR135","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jns.2018.01.008","volume":"386","author":"H An","year":"2018","unstructured":"An H, Zeng X, Niu T, Li G, Yang J, Zheng L, Zhou W, Liu H et al (2018) Quantifying iron deposition within the substantia nigra of Parkinson\u2019s disease by quantitative susceptibility mapping. J Neurol Sci 386:46\u201352","journal-title":"J Neurol Sci"},{"key":"2944_CR136","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","volume":"5","author":"SL Alberico","year":"2015","unstructured":"Alberico SL, Cassell MD, Narayanan NS (2015) The vulnerable ventral tegmental area in Parkinson\u2019s disease. Basal Ganglia 5:51\u201355","journal-title":"Basal Ganglia"},{"key":"2944_CR137","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.parkreldis.2020.08.010","volume":"79","author":"E Porter","year":"2020","unstructured":"Porter E, Roussakis AA, Lao-Kaim NP, Piccini P (2020) Multimodal dopamine transporter (DAT) imaging and magnetic resonance imaging (MRI) to characterise early Parkinson\u2019s disease. Parkinsonism Relat Disord 79:26\u201333","journal-title":"Parkinsonism Relat Disord"},{"key":"2944_CR138","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1212\/WNL.0b013e318248e520","volume":"78","author":"R de la Fuente-Fern\u00e1ndez","year":"2012","unstructured":"de la Fuente-Fern\u00e1ndez R (2012) Role of DaTSCAN and clinical diagnosis in Parkinson disease. Neurology 78:696\u2013701","journal-title":"Neurology"},{"key":"2944_CR139","doi-asserted-by":"publisher","first-page":"104563","DOI":"10.1016\/j.nbd.2019.104563","volume":"132","author":"SW Yoo","year":"2019","unstructured":"Yoo SW, Oh YS, Hwang EJ, Ryu DW, Lee KS, Lyoo CH, Kim JS (2019) \u201cDepressed\u201d caudate and ventral striatum dopamine transporter availability in de novo Depressed Parkinson\u2019s disease. Neurobiol Dis 132:104563","journal-title":"Neurobiol Dis"},{"key":"2944_CR140","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2018.06.022","volume":"56","author":"YS Oh","year":"2018","unstructured":"Oh YS, Kim JS, Hwang EJ, Lyoo CH (2018) Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson\u2019s disease. Parkinsonism Relat Disord 56:47\u201351","journal-title":"Parkinsonism Relat Disord"},{"key":"2944_CR141","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR et al (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 10:204\u2013216","journal-title":"Nat Rev Neurol"},{"key":"2944_CR142","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/jmri.24199","volume":"39","author":"NT Doan","year":"2014","unstructured":"Doan NT, van den Bogaard SJ, Dumas EM, Webb AG, van Buchem MA, Roos RA, van der Grond J, Reiber JH et al (2014) Texture analysis of ultrahigh field T2*-weighted MR images of the brain: application to Huntington\u2019s disease. J Magn Reson Imaging 39:633\u2013640","journal-title":"J Magn Reson Imaging"},{"key":"2944_CR143","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s00018-020-03667-9","volume":"78","author":"W Xu","year":"2021","unstructured":"Xu W, Ocak U, Gao L, Tu S, Lenahan CJ, Zhang J, Shao A (2021) Selective autophagy as a therapeutic target for neurological diseases. Cell Mol Life Sci 78:1369\u20131392","journal-title":"Cell Mol Life Sci"},{"key":"2944_CR144","doi-asserted-by":"crossref","unstructured":"Byrne LM, Rodrigues FB, Johnson EB, Wijeratne PA, De Vita E, Alexander DC, Palermo G, Czech C et al (2018) Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington\u2019s disease. Sci Transl Med 10(458):eaat7108","DOI":"10.1126\/scitranslmed.aat7108"},{"key":"2944_CR145","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1416","volume":"10","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Stockwell BR (2014) The role of iron and reactive oxygen species in cell death. Nat Chem Biol 10:9\u201317","journal-title":"Nat Chem Biol"},{"key":"2944_CR146","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/jnr.24358","volume":"97","author":"L Chen","year":"2019","unstructured":"Chen L, Hua J, Ross CA, Cai S, van Zijl PCM, Li X (2019) Altered brain iron content and deposition rate in Huntington\u2019s disease as indicated by quantitative susceptibility MRI. J Neurosci Res 97:467\u2013479","journal-title":"J Neurosci Res"},{"key":"2944_CR147","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0070-2153(05)70004-1","volume":"70","author":"FE Boada","year":"2005","unstructured":"Boada FE, LaVerde G, Jungreis C, Nemoto E, Tanase C, Hancu I (2005) Loss of cell ion homeostasis and cell viability in the brain: what sodium MRI can tell us. Curr Top Dev Biol 70:77\u2013101","journal-title":"Curr Top Dev Biol"},{"key":"2944_CR148","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.neuroimage.2012.07.009","volume":"63","author":"K Reetz","year":"2012","unstructured":"Reetz K, Romanzetti S, Dogan I, Sa\u00df C, Werner CJ, Schiefer J, Schulz JB, Shah NJ (2012) Increased brain tissue sodium concentration in Huntington\u2019s disease - a sodium imaging study at 4 T. Neuroimage 63:517\u2013524","journal-title":"Neuroimage"},{"key":"2944_CR149","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1007\/s11682-018-9849-5","volume":"12","author":"OFF Odish","year":"2018","unstructured":"Odish OFF, Reijntjes R, van den Bogaard SJA, Roos RAC, Leemans A (2018) Progressive microstructural changes of the occipital cortex in Huntington\u2019s disease. Brain Imaging Behav 12:1786\u20131794","journal-title":"Brain Imaging Behav"},{"key":"2944_CR150","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.parkreldis.2018.02.033","volume":"51","author":"L Nanetti","year":"2018","unstructured":"Nanetti L, Contarino VE, Castaldo A, Sarro L, Bachoud-Levi AC, Giavazzi M, Frittoli S, Ciammola A et al (2018) Cortical thickness, stance control, and arithmetic skill: an exploratory study in premanifest Huntington disease. Parkinsonism Relat Disord 51:17\u201323","journal-title":"Parkinsonism Relat Disord"},{"issue":"23","key":"2944_CR151","doi-asserted-by":"publisher","first-page":"9329","DOI":"10.3390\/ijms21239329","volume":"21","author":"E Wouters","year":"2020","unstructured":"Wouters E, Grajchen E, Jorissen W, Dierckx T, Wetzels S, Loix M, Tulleners MP, Staels B et al (2020) Altered PPAR\u03b3 expression promotes myelin-induced foam cell formation in macrophages in multiple sclerosis. Int J Mol Sci 21(23):9329","journal-title":"Int J Mol Sci"},{"key":"2944_CR152","doi-asserted-by":"publisher","first-page":"606","DOI":"10.4103\/1673-5374.266905","volume":"15","author":"B Martinez","year":"2020","unstructured":"Martinez B, Peplow PV (2020) MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression. Neural Regen Res 15:606\u2013619","journal-title":"Neural Regen Res"},{"key":"2944_CR153","doi-asserted-by":"crossref","unstructured":"Paul A, Comabella M, Gandhi R (2019) Biomarkers in multiple sclerosis. Cold Spring Harb Perspect Med 9(3):a029058","DOI":"10.1101\/cshperspect.a029058"},{"key":"2944_CR154","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1093\/brain\/awz212","volume":"142","author":"C Elliott","year":"2019","unstructured":"Elliott C, Belachew S, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Fecker J et al (2019) Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis. Brain 142:2787\u20132799","journal-title":"Brain"},{"key":"2944_CR155","doi-asserted-by":"publisher","first-page":"10603","DOI":"10.1038\/s41598-019-47112-9","volume":"9","author":"L Lichvarova","year":"2019","unstructured":"Lichvarova L, Blum W, Schwaller B, Szabolcsi V (2019) Parvalbumin expression in oligodendrocyte-like CG4 cells causes a reduction in mitochondrial volume, attenuation in reactive oxygen species production and a decrease in cell processes\u2019 length and branching. Sci Rep 9:10603","journal-title":"Sci Rep"},{"key":"2944_CR156","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/hbm.24510","volume":"40","author":"J O'Muircheartaigh","year":"2019","unstructured":"O\u2019Muircheartaigh J, Vavasour I, Ljungberg E, Li DKB, Rauscher A, Levesque V, Garren H, Clayton D et al (2019) Quantitative neuroimaging measures of myelin in the healthy brain and in multiple sclerosis. Hum Brain Mapp 40:2104\u20132116","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"2944_CR157","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/brainsci10010023","volume":"10","author":"A Gozt","year":"2020","unstructured":"Gozt A, Licari M, Halstrom A, Milbourn H, Lydiard S, Black A, Arendts G, Macdonald S et al (2020) Towards the development of an integrative, evidence-based suite of indicators for the prediction of outcome following mild traumatic brain injury: results from a pilot study. Brain Sci 10(1):23","journal-title":"Brain Sci"},{"key":"2944_CR158","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4103\/2045-9912.196900","volume":"6","author":"L Huang","year":"2016","unstructured":"Huang L, Obenaus A, Hamer M, Zhang JH (2016) Neuroprotective effect of hyperbaric oxygen therapy in a juvenile rat model of repetitive mild traumatic brain injury. Med Gas Res 6:187\u2013193","journal-title":"Med Gas Res"},{"key":"2944_CR159","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.2147\/NDT.S110126","volume":"12","author":"DJ Eve","year":"2016","unstructured":"Eve DJ, Steele MR, Sanberg PR, Borlongan CV (2016) Hyperbaric oxygen therapy as a potential treatment for post-traumatic stress disorder associated with traumatic brain injury. Neuropsychiatr Dis Treat 12:2689\u20132705","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2944_CR160","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/13854046.2011.565076","volume":"25","author":"ML Rohling","year":"2011","unstructured":"Rohling ML, Binder LM, Demakis GJ, Larrabee GJ, Ploetz DM, Langhinrichsen-Rohling J (2011) A meta-analysis of neuropsychological outcome after mild traumatic brain injury: re-analyses and reconsiderations of Binder, et al 2011 1997), Frencham et al. (2005), and Pertab et al. (2009). Clin Neuropsychol 25:608\u2013623","journal-title":"Clin Neuropsychol"},{"key":"2944_CR161","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cjtee.2018.12.004","volume":"22","author":"M Ruslin","year":"2019","unstructured":"Ruslin M, Wolff J, Yusuf HY, Arifin MZ, Boffano P, Forouzanfar T (2019) Use of neuron-specific enolase to predict mild brain injury in motorcycle crash patients with maxillofacial fractures: a pilot study. Chin J Traumatol 22:47\u201350","journal-title":"Chin J Traumatol"},{"key":"2944_CR162","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/B978-0-444-52892-6.00009-X","volume":"127","author":"DI Katz","year":"2015","unstructured":"Katz DI, Cohen SI, Alexander MP (2015) Mild traumatic brain injury. Handb Clin Neurol 127:131\u2013156","journal-title":"Handb Clin Neurol"},{"issue":"Pt 3","key":"2944_CR163","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.expneurol.2015.05.004","volume":"275","author":"JR Kulbe","year":"2016","unstructured":"Kulbe JR, Geddes JW (2016) Current status of fluid biomarkers in mild traumatic brain injury. Exp Neurol 275(Pt 3):334\u2013352","journal-title":"Exp Neurol"},{"key":"2944_CR164","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3174\/ajnr.A1806","volume":"31","author":"Z Chu","year":"2010","unstructured":"Chu Z, Wilde EA, Hunter JV, McCauley SR, Bigler ED, Troyanskaya M, Yallampalli R, Chia JM et al (2010) Voxel-based analysis of diffusion tensor imaging in mild traumatic brain injury in adolescents. AJNR Am J Neuroradiol 31:340\u2013346","journal-title":"AJNR Am J Neuroradiol"},{"key":"2944_CR165","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1212\/WNL.0b013e3182929f38","volume":"80","author":"AS Pandit","year":"2013","unstructured":"Pandit AS, Expert P, Lambiotte R, Bonnelle V, Leech R, Turkheimer FE, Sharp DJ (2013) Traumatic brain injury impairs small-world topology. Neurology 80:1826\u20131833","journal-title":"Neurology"},{"key":"2944_CR166","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.neuroimage.2009.10.003","volume":"52","author":"M Rubinov","year":"2010","unstructured":"Rubinov M, Sporns O (2010) Complex network measures of brain connectivity: uses and interpretations. Neuroimage 52:1059\u20131069","journal-title":"Neuroimage"},{"key":"2944_CR167","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2012-302742","volume":"83","author":"Y Aoki","year":"2012","unstructured":"Aoki Y, Inokuchi R, Gunshin M, Yahagi N, Suwa H (2012) Diffusion tensor imaging studies of mild traumatic brain injury: a meta-analysis. J Neurol Neurosurg Psychiatry 83:870\u2013876","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2944_CR168","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-bioeng-071811-150032","volume":"14","author":"PV Bayly","year":"2012","unstructured":"Bayly PV, Clayton EH, Genin GM (2012) Quantitative imaging methods for the development and validation of brain biomechanics models. Annu Rev Biomed Eng 14:369\u2013396","journal-title":"Annu Rev Biomed Eng"},{"key":"2944_CR169","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1089\/neu.2012.2630","volume":"30","author":"MJ Hylin","year":"2013","unstructured":"Hylin MJ, Orsi SA, Zhao J, Bockhorst K, Perez A, Moore AN, Dash PK (2013) Behavioral and histopathological alterations resulting from mild fluid percussion injury. J Neurotrauma 30:702\u2013715","journal-title":"J Neurotrauma"},{"key":"2944_CR170","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1089\/neu.2015.3880","volume":"33","author":"IK Koerte","year":"2016","unstructured":"Koerte IK, Hufschmidt J, Muehlmann M, Tripodis Y, Stamm JM, Pasternak O, Giwerc MY, Coleman MJ et al (2016) Cavum Septi pellucidi in symptomatic former professional football players. J Neurotrauma 33:346\u2013353","journal-title":"J Neurotrauma"},{"key":"2944_CR171","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/neu.2014.3805","volume":"33","author":"RC Gardner","year":"2016","unstructured":"Gardner RC, Hess CP, Brus-Ramer M, Possin KL, Cohn-Sheehy BI, Kramer JH, Berger MS, Yaffe K et al (2016) Cavum septum pellucidum in retired american pro-football players. J Neurotrauma 33:157\u2013161","journal-title":"J Neurotrauma"},{"key":"2944_CR172","doi-asserted-by":"publisher","first-page":"427","DOI":"10.7863\/jum.2010.29.3.427","volume":"29","author":"TC Winter","year":"2010","unstructured":"Winter TC, Kennedy AM, Byrne J, Woodward PJ (2010) The cavum septi pellucidi: why is it important? J Ultrasound Med 29:427\u2013444","journal-title":"J Ultrasound Med"},{"key":"2944_CR173","doi-asserted-by":"crossref","unstructured":"Zeiler FA, Ercole A, Czosnyka M, Smielewski P, Hawryluk G, Hutchinson PJA, Menon DK, Aries M (2020) Continuous cerebrovascular reactivity monitoring in moderate\/severe traumatic brain injury: a narrative review of advances in neurocritical care. Br J Anaesth S0007-0912(19)30966-3","DOI":"10.1016\/j.bja.2019.11.031"},{"key":"2944_CR174","doi-asserted-by":"publisher","first-page":"10149","DOI":"10.1038\/s41598-017-09752-7","volume":"7","author":"DD Garrett","year":"2017","unstructured":"Garrett DD, Lindenberger U, Hoge RD, Gauthier CJ (2017) Age differences in brain signal variability are robust to multiple vascular controls. Sci Rep 7:10149","journal-title":"Sci Rep"},{"key":"2944_CR175","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fped.2017.00205","volume":"5","author":"AMH Young","year":"2017","unstructured":"Young AMH, Adams H, Donnelly J, Guilfoyle MR, Fernandes H, Garnett MR, Czosnyka M, Smielewski P et al (2017) Glycemia is related to impaired cerebrovascular autoregulation after severe pediatric traumatic brain injury: a retrospective observational study. Front Pediatr 5:205","journal-title":"Front Pediatr"},{"key":"2944_CR176","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fnmol.2018.00338","volume":"11","author":"P Bazzigaluppi","year":"2018","unstructured":"Bazzigaluppi P, Adams C, Koletar MM, Dorr A, Pikula A, Carlen PL, Stefanovic B (2018) Oophorectomy reduces estradiol levels and long-term spontaneous neurovascular recovery in a female rat model of focal ischemic stroke. Front Mol Neurosci 11:338","journal-title":"Front Mol Neurosci"},{"key":"2944_CR177","first-page":"320","volume":"49","author":"BB Forster","year":"1998","unstructured":"Forster BB, MacKay AL, Whittall KP, Kiehl KA, Smith AM, Hare RD, Liddle PF (1998) Functional magnetic resonance imaging: the basics of blood-oxygen-level dependent (BOLD) imaging. Can Assoc Radiol J 49:320\u2013329","journal-title":"Can Assoc Radiol J"},{"key":"2944_CR178","doi-asserted-by":"publisher","first-page":"e0186641","DOI":"10.1371\/journal.pone.0186641","volume":"12","author":"F Claren\u00e7on","year":"2017","unstructured":"Claren\u00e7on F, Bardinet \u00c9, Martinerie J, Pelbarg V, Menjot de Champfleur N, Gupta R, Tollard E, Soto-Ares G et al (2017) Lesions in deep gray nuclei after severe traumatic brain injury predict neurologic outcome. PLoS One 12:e0186641","journal-title":"PLoS One"},{"key":"2944_CR179","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1177\/0271678X20985156","volume":"41","author":"M Haber","year":"2021","unstructured":"Haber M, Amyot F, Lynch CE, Sandsmark DK, Kenney K, Werner JK, Moore C, Flesher K et al (2021) Imaging biomarkers of vascular and axonal injury are spatially distinct in chronic traumatic brain injury. J Cereb Blood Flow Metab 41:1924\u20131938","journal-title":"J Cereb Blood Flow Metab"},{"key":"2944_CR180","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1089\/neu.2017.5085","volume":"34","author":"FA Zeiler","year":"2017","unstructured":"Zeiler FA, Donnelly J, Calviello L, Menon DK, Smielewski P, Czosnyka M (2017) Pressure autoregulation measurement techniques in adult traumatic brain injury, part i: a scoping review of intermittent\/semi-intermittent methods. J Neurotrauma 34:3207\u20133223","journal-title":"J Neurotrauma"},{"key":"2944_CR181","doi-asserted-by":"publisher","first-page":"e5670","DOI":"10.1590\/1414-431x20175670","volume":"50","author":"RF Leoni","year":"2017","unstructured":"Leoni RF, Oliveira IA, Pontes-Neto OM, Santos AC, Leite JP (2017) Cerebral blood flow and vasoreactivity in aging: an arterial spin labeling study. Braz J Med Biol Res 50:e5670","journal-title":"Braz J Med Biol Res"},{"key":"2944_CR182","doi-asserted-by":"crossref","unstructured":"Hannan MA, Rahman MA, Sohag AAM, Uddin MJ, Dash R, Sikder MH, Rahman MS, Timalsina B et al (2021) Black cumin (Nigella sativa L.): a comprehensive review on phytochemistry, health benefits, molecular pharmacology, and safety. Nutrients 13(6):1784","DOI":"10.3390\/nu13061784"},{"key":"2944_CR183","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1007\/s12035-020-02206-8","volume":"58","author":"M Wolska","year":"2021","unstructured":"Wolska M, Jarosz-Popek J, Junger E, Wicik Z, Porshoor T, Sharif L, Czajka P, Postula M et al (2021) Long non-coding RNAs as promising therapeutic approach in ischemic stroke: a comprehensive review. Mol Neurobiol 58:1664\u20131682","journal-title":"Mol Neurobiol"},{"key":"2944_CR184","doi-asserted-by":"publisher","first-page":"652820","DOI":"10.3389\/fimmu.2021.652820","volume":"12","author":"TY Zhang","year":"2021","unstructured":"Zhang TY, Cai MT, Zheng Y, Lai QL, Shen CH, Qiao S, Zhang YX (2021) Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis: a review. Front Immunol 12:652820","journal-title":"Front Immunol"},{"key":"2944_CR185","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/1673-5374.286954","volume":"16","author":"W Zhang","year":"2021","unstructured":"Zhang W, Tian T, Gong SX, Huang WQ, Zhou QY, Wang AP, Tian Y (2021) Microglia-associated neuroinflammation is a potential therapeutic target for ischemic stroke. Neural Regen Res 16:6\u201311","journal-title":"Neural Regen Res"},{"key":"2944_CR186","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1177\/0271678X17726635","volume":"39","author":"S Koch","year":"2019","unstructured":"Koch S, Mueller S, Foddis M, Bienert T, von Elverfeldt D, Knab F, Farr TD, Bernard R, et al (2019) Atlas registration for edema-corrected MRI lesion volume in mouse stroke models. J Cereb Blood Flow Metab 39:313\u2013323","journal-title":"J Cereb Blood Flow Metab"},{"key":"2944_CR187","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/01.STR.0000113692.38574.57","volume":"35","author":"T Gerriets","year":"2004","unstructured":"Gerriets T, Stolz E, Walberer M, M\u00fcller C, Kluge A, Bachmann A, Fisher M, Kaps M, et al (2004) Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke 35:566\u2013571","journal-title":"Stroke"},{"key":"2944_CR188","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s12035-018-1073-1","volume":"56","author":"Y Nakajo","year":"2019","unstructured":"Nakajo Y, Zhao Q, Enmi JI, Iida H, Takahashi JC, Kataoka H, Yamato K, Yanamoto H (2019) Early detection of cerebral infarction after focal ischemia using a new MRI indicator. Mol Neurobiol 56:658\u2013670","journal-title":"Mol Neurobiol"},{"key":"2944_CR189","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12987-018-0105-6","volume":"15","author":"J Rey","year":"2018","unstructured":"Rey J, Sarntinoranont M (2018) Pulsatile flow drivers in brain parenchyma and perivascular spaces: a resistance network model study. Fluids Barriers CNS 15:20","journal-title":"Fluids Barriers CNS"},{"key":"2944_CR190","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jad.2017.11.080","volume":"228","author":"Y Liang","year":"2018","unstructured":"Liang Y, Chan YL, Deng M, Chen YK, Mok V, Wang F, Ungvari GS, Chu CW, et al (2018) Enlarged perivascular spaces in the centrum semiovale are associated with poststroke depression: a 3-month prospective study. J Affect Disord 228:166\u2013172","journal-title":"J Affect Disord"},{"key":"2944_CR191","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/cvr\/cvy113","volume":"114","author":"R Brown","year":"2018","unstructured":"Brown R, Benveniste H, Black SE, Charpak S, Dichgans M, Joutel A, Nedergaard M, Smith KJ, et al (2018) Understanding the role of the perivascular space in cerebral small vessel disease. Cardiovasc Res 114:1462\u20131473","journal-title":"Cardiovasc Res"},{"key":"2944_CR192","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, Sepehrband F, Nelson AR, et al (2019) Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med 25:270\u2013276","journal-title":"Nat Med"},{"key":"2944_CR193","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.neubiorev.2019.05.016","volume":"103","author":"S Sundaram","year":"2019","unstructured":"Sundaram S, Hughes RL, Peterson E, M\u00fcller-Oehring EM, Bront\u00eb-Stewart HM, Poston KL, Faerman A, Bhowmick C, et al (2019) Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson\u2019s disease. Neurosci Biobehav Rev 103:305\u2013315","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"2944_CR194","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/cns.13786","volume":"28","author":"N Yu","year":"2022","unstructured":"Yu N, Sinclair B, Posada LMG, Chen Z, Di Q, Lin X, Kolbe S, Hlauschek G, Kwan P et al (2022) Asymmetric distribution of enlarged perivascular spaces in centrum semiovale may be associated with epilepsy after acute ischemic stroke. CNS Neurosci Ther 28(3):343\u2013353","journal-title":"CNS Neurosci Ther"},{"key":"2944_CR195","doi-asserted-by":"publisher","first-page":"e0215814","DOI":"10.1371\/journal.pone.0215814","volume":"14","author":"A Shahid","year":"2019","unstructured":"Shahid A, Patel VB, Morton JS, Stenson TH, Davidge ST, Oudit GY, McMurtry MS (2019) Low altitude simulation without hypoxia improves left ventricular function after myocardial infarction by reducing ventricular afterload. PLoS ONE 14:e0215814","journal-title":"PLoS ONE"},{"key":"2944_CR196","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12975-016-0497-z","volume":"8","author":"ET Mandeville","year":"2017","unstructured":"Mandeville ET, Ayata C, Zheng Y, Mandeville JB (2017) Translational MR neuroimaging of stroke and recovery. Transl Stroke Res 8:22\u201332","journal-title":"Transl Stroke Res"},{"key":"2944_CR197","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/jmri.26949","volume":"51","author":"S Jin","year":"2020","unstructured":"Jin S, Han S, Stoyanova R, Ackerstaff E, Cho H (2020) Pattern recognition analysis of dynamic susceptibility contrast (DSC)-MRI curves automatically segments tissue areas with intact blood-brain barrier in a rat stroke model: a feasibility and comparison study. J Magn Reson Imaging 51:1369\u20131381","journal-title":"J Magn Reson Imaging"},{"key":"2944_CR198","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/RCT.0000000000000283","volume":"39","author":"WY Huang","year":"2015","unstructured":"Huang WY, Wu G, Li JJ, Geng DY, Tan WL, Yu XR (2015) Prediction of reperfusion-associated hemorrhagic transformation using dynamic contrast-enhanced imaging in a rat stroke model. J Comput Assist Tomogr 39:787\u2013793","journal-title":"J Comput Assist Tomogr"},{"key":"2944_CR199","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11548-019-02060-7","volume":"15","author":"MNN To","year":"2020","unstructured":"To MNN, Kim HJ, Roh HG, Cho YS, Kwak JT (2020) Deep regression neural networks for collateral imaging from dynamic susceptibility contrast-enhanced magnetic resonance perfusion in acute ischemic stroke. Int J Comput Assist Radiol Surg 15:151\u2013162","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"2944_CR200","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1177\/1747493019873515","volume":"15","author":"G Zhu","year":"2020","unstructured":"Zhu G, Federau C, Wintermark M, Chen H, Marcellus DG, Martin BW, Heit JJ (2020) Comparison of MRI IVIM and MR perfusion imaging in acute ischemic stroke due to large vessel occlusion. Int J Stroke 15:332\u2013342","journal-title":"Int J Stroke"},{"key":"2944_CR201","doi-asserted-by":"publisher","first-page":"105908","DOI":"10.1016\/j.clineuro.2020.105908","volume":"194","author":"A Aracki-Trenkic","year":"2020","unstructured":"Aracki-Trenkic A, Law-Ye B, Radovanovic Z, Stojanov D, Dormont D, Pyatigorskaya N (2020) ASL perfusion in acute ischemic stroke: the value of CBF in outcome prediction. Clin Neurol Neurosurg 194:105908","journal-title":"Clin Neurol Neurosurg"},{"key":"2944_CR202","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s11596-015-1529-8","volume":"35","author":"SX Zhang","year":"2015","unstructured":"Zhang SX, Yao YH, Zhang S, Zhu WJ, Tang XY, Qin YY, Zhao LY, Liu CX, Zhu WZ (2015) Comparative study of DSC-PWI and 3D-ASL in ischemic stroke patients. J Huazhong Univ Sci Technolog Med Sci 35:923\u2013927","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"2944_CR203","doi-asserted-by":"publisher","first-page":"e1338","DOI":"10.1212\/WNL.0000000000006282","volume":"91","author":"S Tiedt","year":"2018","unstructured":"Tiedt S, Duering M, Barro C, Kaya AG, Boeck J, Bode FJ, Klein M, Dorn F, et al (2018) Serum neurofilament light: a biomarker of neuroaxonal injury after ischemic stroke. Neurology 91:e1338\u2013e1347","journal-title":"Neurology"},{"key":"2944_CR204","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/10408363.2018.1461190","volume":"55","author":"K Makris","year":"2018","unstructured":"Makris K, Haliassos A, Chondrogianni M, Tsivgoulis G (2018) Blood biomarkers in ischemic stroke: potential role and challenges in clinical practice and research. Crit Rev Clin Lab Sci 55:294\u2013328","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2944_CR205","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1474-4422(16)30199-5","volume":"15","author":"A Al-Chalabi","year":"2016","unstructured":"Al-Chalabi A, Hardiman O, Kiernan MC, Chi\u00f2 A, Rix-Brooks B, van den Berg LH (2016) Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol 15:1182\u20131194","journal-title":"Lancet Neurol"},{"key":"2944_CR206","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/brain.2011.0071","volume":"1","author":"AL Alexander","year":"2011","unstructured":"Alexander AL, Hurley SA, Samsonov AA, Adluru N, Hosseinbor AP, Mossahebi P (2011) Tromp do PM, Zakszewski E, Field AS: Characterization of cerebral white matter properties using quantitative magnetic resonance imaging stains. Brain Connect 1:423\u2013446","journal-title":"Brain Connect"},{"key":"2944_CR207","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1038\/s41598-020-62049-0","volume":"10","author":"SH Baek","year":"2020","unstructured":"Baek SH, Park J, Kim YH, Seok HY, Oh KW, Kim HJ, Kwon YJ, Sim Y, et al (2020) Usefulness of diffusion tensor imaging findings as biomarkers for amyotrophic lateral sclerosis. Sci Rep 10:5199","journal-title":"Sci Rep"},{"key":"2944_CR208","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00415-014-7551-0","volume":"262","author":"F Sacc\u00e0","year":"2015","unstructured":"Sacc\u00e0 F, Puorro G, Brunetti A, Capasso G, Cervo A, Cocozza S, de Leva M, Marsili A, et al (2015) A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. J Neurol 262:149\u2013153","journal-title":"J Neurol"},{"issue":"3","key":"2944_CR209","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/ijms21031020","volume":"21","author":"M Mascalchi","year":"2020","unstructured":"Mascalchi M, Vella A (2020) Neuroimaging biomarkers in SCA2 gene carriers. Int J Mol Sci 21(3):1020","journal-title":"Int J Mol Sci"},{"key":"2944_CR210","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","volume":"6","author":"GB Frisoni","year":"2010","unstructured":"Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6:67\u201377","journal-title":"Nat Rev Neurol"},{"key":"2944_CR211","first-page":"Cd009628","volume":"3","author":"G Lombardi","year":"2020","unstructured":"Lombardi G, Crescioli G, Cavedo E, Lucenteforte E, Casazza G, Bellatorre AG, Lista C, Costantino G, et al (2020) Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer\u2019s disease in people with mild cognitive impairment. Cochrane Database Syst Rev 3:Cd009628","journal-title":"Cochrane Database Syst Rev"},{"key":"2944_CR212","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers and surrogate endpoints","year":"2001","unstructured":"Biomarkers and surrogate endpoints (2001) preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89\u201395","journal-title":"Clin Pharmacol Ther"},{"key":"2944_CR213","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13195-020-00601-w","volume":"12","author":"AJ Ehrenberg","year":"2020","unstructured":"Ehrenberg AJ, Khatun A, Coomans E, Betts MJ, Capraro F, Thijssen EH, Senkevich K, Bharucha T, et al (2020) Relevance of biomarkers across different neurodegenerative diseases. Alzheimers Res Ther 12:56","journal-title":"Alzheimers Res Ther"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-02944-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-022-02944-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-02944-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T20:51:24Z","timestamp":1666558284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-022-02944-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":213,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["2944"],"URL":"https:\/\/doi.org\/10.1007\/s12035-022-02944-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,12]]},"assertion":[{"value":"10 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable<b>.<\/b>","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors mentioned have participated in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors approved the publication of article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}